| Literature DB >> 32837326 |
Gylych Jelilov1, Paul Terhemba Iorember2, Ojonugwa Usman3, Paul M Yua4.
Abstract
Given the palpable fear generated by the threat of COVID-19 pandemic and the bearish sentiments of stock investors, this study represents one of the first efforts towards testing the effect of COVID-19 on the stock market returns-inflation relationship. Specifically, the study investigates the stock market returns-inflation nexus by controlling for the effect of COVID-19 pandemic in Nigeria from February 27, 2020 to April 30, 2020. Using the estimation procedures based on the generalized autoregressive conditional heteroskedasticity type models (GARCH (1,1), the GJR-GARCH), and the accounting innovation tests, our results show that COVID-19 increases volatility and distorts the positive relationship between inflation and stock market returns, which tends to negate the Fisher's hypothesis. In addition, the results reveal that the negative effects of COVID-19 on the market returns and its disruption to the stock market returns-inflation relationship may not die away rapidly considering that the duration of the pandemic is unknown. Further, these findings are validated by the innovation accounting tests. Therefore, the study presents to policymakers the consequences of COVID-19 and the urgent need to strengthen the market through collaborative efforts.Entities:
Year: 2020 PMID: 32837326 PMCID: PMC7435360 DOI: 10.1002/pa.2289
Source DB: PubMed Journal: J Public Aff ISSN: 1472-3891
Descriptive statistics and correlation matrix
| Descriptive Statistics | |||
|---|---|---|---|
| SMR | INF | COVID19 | |
| Mean | −0.330605 | 12.29875 | 33.43478 |
| Std. Dev. | 1.590511 | 0.047623 | 53.63235 |
| Maximum | 2.971815 | 12.38405 | 204.0000 |
| Minimum | −5.032939 | 12.22293 | 0.000000 |
| Correlation Matrix | |||
| SMR | 1 | ||
| INF | 0.514830 | 1 | |
| (0.0000) | |||
| COVID‐19 | 0.228431 | 0.679791 | 1 |
| (0.0000) | (0.0000) | ||
Source: Authors’ computation.
FIGURE 1Time plot of SMR, INF, and COVID‐19 over the study period
FIGURE 2Trend analysis of stock market returns and growth rate of COVID‐19
Results of unit root and ARCH effect tests
| ADF in Levels | ADF in First Difference | ARCH Effect | |||
|---|---|---|---|---|---|
| Test Statistic | 5% CV | Test Statistic | 5% CV | LM | |
| SMR | −3.7863** | −2.9350 | −5.6012** | −2.9369 | 4.7364** |
| INF | −4.8977** | −2.9350 | −6.2890** | −2.9369 | ‐ |
| COVID_19 | −2.9764*** | −2.9350 | −4.7785** | −2.9369 | ‐ |
Note: ** indicates significance at 5% level of significance. CV implies critical values and LM stands for Lagrange multiplier.
Results of GARCH (1,1) with inflation and COVID‐19
| Coefficient |
| |
|---|---|---|
| Conditional mean equation | ||
|
| .5909*** | .0073 |
| Conditional variance equation | ||
|
| .9621** | .0717 |
|
| .2486** | .0349 |
|
| .6213** | .0294 |
|
| .8699 | |
| INF | .8712** | .0286 |
| COVID‐19 | .4693*** | .0034 |
Note: *** and ** indicate 1 and 5% level of significance.
Results of GJR‐GARCH with inflation and COVID‐19
| Coefficient |
| |
|---|---|---|
| Conditional mean equation | ||
|
| .3027** | .0390 |
| Conditional variance equation | ||
|
| 1.0372** | .0362 |
|
| .5199* | .0480 |
|
| .2671** | .0244 |
|
| .7129*** | .0001 |
|
| .9799 | |
| INF | .7185** | .022 |
| COVID‐19 | .1833** | .005 |
Note: ***, ** and * indicate 1, 5 and 10% level of significance.
Estimates of the VAR model
| Equations | |||||
|---|---|---|---|---|---|
| Variables | SMR | INF | COVID‐19 | ||
|
|
0.0977 (0.1604) |
0.0003 (0.0002) |
0.0134 (2.3247) | ||
|
|
0.2709 (0.1602) |
−0.0002 (0.0002) |
0.1018 (2.322) | ||
|
|
−86.156 (117.31) |
0.8315*** (0.1617) |
4,578.2*** (1700.3) | ||
|
|
100.11 (119.14) |
0.1843 (0.1643) |
−4,458.2*** (1726.9) | ||
|
|
0.0018 (0.0097) |
−5.34E‐1 (1.3E‐05) |
0.5634*** (0.1405) | ||
|
|
−0.0092 (0.0109) |
−3.22E‐1 (1.5E‐05) |
0.4688 (0.1583) | ||
| Constant |
−171.17 (118.37) |
−0.1909 (0.1632) |
−1,486.2 (1715.7) | ||
|
| 0.2669 | 0.9983 | 0.8684 | ||
| Adj. | 0.1479 | 0.9981 | 0.8470 | ||
|
| 2.2448 | 3,699.3 | 40.680 | ||
| Akaike AIC | 3.7494 | −9.4240 | 9.0969 | ||
| Schwarz SC | 4.0333 | −9.1402 | 9.3807 | ||
Note: *** denotes significance 1% while standard errors are presented in parentheses.
FIGURE 3Impulse response function to inflation and COVID‐19 shocks
Forecast error variance decomposition
| Variance Decomposition of SMR | ||||
| Period | S.E. | SMR | INF | COVID19 |
| 1 | 1.467142 | 100.0000 | 0.000000 | 0.000000 |
| 2 | 1.488827 | 98.48509 | 1.453872 | 0.061035 |
| 3 | 1.544952 | 97.22563 | 1.697149 | 1.077224 |
| 4 | 1.554762 | 96.74465 | 1.911476 | 1.343871 |
| 5 | 1.565955 | 95.68395 | 1.939331 | 2.376720 |
| 6 | 1.573773 | 94.90944 | 1.928798 | 3.161764 |
| 7 | 1.582349 | 93.91087 | 1.911692 | 4.177437 |
| 8 | 1.590923 | 92.93157 | 1.891146 | 5.177285 |
| 9 | 1.599759 | 91.91422 | 1.870342 | 6.215438 |
| 10 | 1.608886 | 90.88101 | 1.849205 | 7.269787 |
| Variance Decomposition of INF | ||||
| Period | S.E. | SMR | INF | COVID19 |
| 1 | 0.002023 | 3.398823 | 96.60118 | 0.000000 |
| 2 | 0.002631 | 2.090842 | 97.73218 | 0.176974 |
| 3 | 0.003138 | 2.236676 | 97.40600 | 0.357329 |
| 4 | 0.003617 | 1.881154 | 97.23571 | 0.883140 |
| 5 | 0.004025 | 1.820253 | 96.78938 | 1.390365 |
| 6 | 0.004424 | 1.751342 | 96.13105 | 2.117608 |
| 7 | 0.004792 | 1.699011 | 95.37614 | 2.924850 |
| 8 | 0.005150 | 1.661148 | 94.46663 | 3.872221 |
| 9 | 0.005495 | 1.618547 | 93.45207 | 4.929385 |
| 10 | 0.005832 | 1.580026 | 92.32030 | 6.099678 |
| Variance Decomposition of COVID19 | ||||
| Period | S.E. | SMR | INF | COVID19 |
| 1 | 21.26473 | 0.035684 | 4.788704 | 95.17561 |
| 2 | 25.18841 | 0.602702 | 10.02927 | 89.36803 |
| 3 | 29.75137 | 0.522268 | 7.198011 | 92.27972 |
| 4 | 33.19393 | 0.770548 | 6.831580 | 92.39787 |
| 5 | 36.42628 | 0.641762 | 6.203465 | 93.15477 |
| 6 | 39.42475 | 0.655470 | 5.907505 | 93.43702 |
| 7 | 42.21288 | 0.608397 | 5.803977 | 93.58763 |
| 8 | 44.87181 | 0.596150 | 5.755608 | 93.64824 |
| 9 | 47.39188 | 0.582533 | 5.827666 | 93.58980 |
| 10 | 49.80896 | 0.575407 | 5.941861 | 93.48273 |
| Cholesky ordering: SMR INF COVID19 | ||||